CyA-246

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCyA-246
Drug Alias NameCyA-246
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulantsCytokines stimulants
TargetsCytokines
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A